Evidence map›Paper›PMID 39502513›Full record

ArticleInternational journal of microbiology2024

Thayana Cruz de Souza, Marcos Gustavo Araujo Schwarz, Daniela Marinho da Silva, Carolina Rabelo Maia, Cláudia Patrícia Mendes de Araújo, Antônio Alcirley da Silva Balieiro, Luiz Antonio de Oliveira, Wim Maurits Sylvain Degrave, Ormezinda Celeste Cristo Fernandes, Leila Mendonça-Lima

Abstract read
In one paragraph

Article in International journal of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thayana Cruz de SouzaLeônidas and Maria Deane Institute, ILMD/Fiocruz, Rua Teresina, 476, Adrianópolis, Manaus, Amazonas 69057-070, Brazil.ORCID https://orcid.org/0000-0002-1178-4272
Marcos Gustavo Araujo SchwarzOswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, State of Rio de Janeiro 21040-360, Brazil.ORCID https://orcid.org/0000-0002-6858-0860
Daniela Marinho da SilvaLeônidas and Maria Deane Institute, ILMD/Fiocruz, Rua Teresina, 476, Adrianópolis, Manaus, Amazonas 69057-070, Brazil.ORCID https://orcid.org/0000-0002-3813-4624
Carolina Rabelo MaiaLeônidas and Maria Deane Institute, ILMD/Fiocruz, Rua Teresina, 476, Adrianópolis, Manaus, Amazonas 69057-070, Brazil.ORCID https://orcid.org/0000-0001-5050-6112
Cláudia Patrícia Mendes de AraújoLeônidas and Maria Deane Institute, ILMD/Fiocruz, Rua Teresina, 476, Adrianópolis, Manaus, Amazonas 69057-070, Brazil.ORCID https://orcid.org/0000-0002-7804-4447
Antônio Alcirley da Silva BalieiroLeônidas and Maria Deane Institute, ILMD/Fiocruz, Rua Teresina, 476, Adrianópolis, Manaus, Amazonas 69057-070, Brazil.ORCID https://orcid.org/0000-0003-0358-3371
Luiz Antonio de OliveiraNational Institute for Amazon Research, INPA, Av. André Araújo, 2.936, Petrópolis, Manaus, Amazonas 69080-971, Brazil.ORCID https://orcid.org/0000-0002-2008-7292
Wim Maurits Sylvain DegraveOswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, State of Rio de Janeiro 21040-360, Brazil.ORCID https://orcid.org/0000-0003-3533-4580
Ormezinda Celeste Cristo FernandesLeônidas and Maria Deane Institute, ILMD/Fiocruz, Rua Teresina, 476, Adrianópolis, Manaus, Amazonas 69057-070, Brazil.ORCID https://orcid.org/0000-0001-5752-5017
Leila Mendonça-LimaOswaldo Cruz Institute, Fiocruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro, State of Rio de Janeiro 21040-360, Brazil.ORCID https://orcid.org/0000-0003-4388-5083

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrinolytic agents are essential in treating thrombosis, playing a critical role in improving survival rates in cardiovascular diseases. Microbial fibrinolytic proteases have emerged as promising alternatives due to their affordability, specificity, lower toxicity, and reduced side effects. Consequently, the search for microorganisms capable of producing these enzymes has gained significant economic importance in the pharmaceutical industry. This study reports and characterizes a novel fibrinolytic enzyme produced by

Indexed as

fibrinolytic enzymePEG/phosphatePenicilliumthrombolytic activity

Identifiers

PMID39502513
PMCPMC11537737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.